Dr. Martens plc (LON:DOCS – Get Free Report) shares hit a new 52-week low during trading on Thursday . The company traded as low as GBX 47.52 ($0.62) and last traded at GBX 49.56 ($0.64), with a volume of 3938522 shares. The stock had previously closed at GBX 53 ($0.69).
Dr. Martens Stock Down 6.5 %
The company has a market capitalization of £481.11 million, a price-to-earnings ratio of 7.03, a P/E/G ratio of 6.40 and a beta of 0.11. The business has a fifty day simple moving average of GBX 63.45 and a two-hundred day simple moving average of GBX 63.17. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27.
Dr. Martens Cuts Dividend
The business also recently declared a dividend, which will be paid on Tuesday, April 8th. Investors of record on Thursday, March 6th will be paid a GBX 0.85 ($0.01) dividend. This represents a yield of 1.47%. The ex-dividend date of this dividend is Thursday, March 6th. Dr. Martens’s dividend payout ratio is 42.53%.
Insider Buying and Selling at Dr. Martens
About Dr. Martens
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Read More
- Five stocks we like better than Dr. Martens
- 3 Healthcare Dividend Stocks to Buy
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- How to buy stock: A step-by-step guide for beginners
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.